The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2009-08-12

AUTHORS

Stefano Ferrari , Emanuela Palmerini , Eric L. Staals , Mario Mercuri , Bertoni Franco , Piero Picci , Gaetano Bacci

ABSTRACT

The Bone Tumor Center of the “Istituto Ortopedico Rizzoli” was established in 1955 with the aim of studying and treating the musculoskeletal tumors. Between 1959 and 2006, 1245 patients with high grade nonmetastatic osteosarcoma of the extremity were treated at our Institute. Most of them were enrolled in study protocols.In the “prechemotherapy era”, the cure rate was 11%, with an amputation rate of 90%. Our first experience with adjuvant chemotherapy was in 1972. A total of 223 patients received adjuvant chemotherapy, with a disease-free survival (DFS) ranging from 45% to 53%, according to the chemotherapy protocol used. With the introduction of neoadjuvant chemotherapy, the resection rate increased and reached 94%, when high dose fosfamide was added to standard doses of methotrexate, cisplatin, and adriamycin.In the last few years, the results of treatment of nonmetastatic osteosarcoma of the extremity have reached a plateau (64% five-year DFS), and strategies of dose intensification are not able to improve the prognosis. Not only new active drugs, but also different approaches to the disease, are needed.In this regard, we are now investigating tumor microenvironment-targeted agents and chemotherapy protocols based on prospective biological stratification of patients.Collaborative projects with international groups and institutions are crucial for this rare disease. More... »

PAGES

275-287

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14

DOI

http://dx.doi.org/10.1007/978-1-4419-0284-9_14

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009972078

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20213396


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Extremities", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sezione di Chemioterapia, dei Tumori dell\u2019 Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Sezione di Chemioterapia, dei Tumori dell\u2019 Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "Stefano", 
        "id": "sg:person.013005321532.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Palmerini", 
        "givenName": "Emanuela", 
        "id": "sg:person.01210215667.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Staals", 
        "givenName": "Eric L.", 
        "id": "sg:person.01324444267.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324444267.96"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Mercuri", 
        "givenName": "Mario", 
        "id": "sg:person.01062073475.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062073475.32"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Franco", 
        "givenName": "Bertoni", 
        "type": "Person"
      }, 
      {
        "familyName": "Picci", 
        "givenName": "Piero", 
        "id": "sg:person.0753274552.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Bacci", 
        "givenName": "Gaetano", 
        "id": "sg:person.01275050611.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275050611.54"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2009-08-12", 
    "datePublishedReg": "2009-08-12", 
    "description": "The Bone Tumor Center of the \u201cIstituto Ortopedico Rizzoli\u201d was established in 1955 with the aim of studying and treating the musculoskeletal tumors. Between 1959 and 2006, 1245 patients with high grade nonmetastatic osteosarcoma of the extremity were treated at our Institute. Most of them were enrolled in study protocols.In the \u201cprechemotherapy era\u201d, the cure rate was 11%, with an amputation rate of 90%. Our first experience with adjuvant chemotherapy was in 1972. A total of 223 patients received adjuvant chemotherapy, with a disease-free survival (DFS) ranging from 45% to 53%, according to the chemotherapy protocol used. With the introduction of neoadjuvant chemotherapy, the resection rate increased and reached 94%, when high dose fosfamide was added to standard doses of methotrexate, cisplatin, and adriamycin.In the last few years, the results of treatment of nonmetastatic osteosarcoma of the extremity have reached a plateau (64% five-year DFS), and strategies of dose intensification are not able to improve the prognosis. Not only new active drugs, but also different approaches to the disease, are needed.In this regard, we are now investigating tumor microenvironment-targeted agents and chemotherapy protocols based on prospective biological stratification of patients.Collaborative projects with international groups and institutions are crucial for this rare disease.", 
    "editor": [
      {
        "familyName": "Jaffe", 
        "givenName": "Norman", 
        "type": "Person"
      }, 
      {
        "familyName": "Bruland", 
        "givenName": "Oyvind S.", 
        "type": "Person"
      }, 
      {
        "familyName": "Bielack", 
        "givenName": "Stefan", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4419-0284-9_14", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4419-0283-2", 
        "978-1-4419-0284-9"
      ], 
      "name": "Pediatric and Adolescent Osteosarcoma", 
      "type": "Book"
    }, 
    "keywords": [
      "disease-free survival", 
      "adjuvant chemotherapy", 
      "nonmetastatic osteosarcoma", 
      "chemotherapy protocols", 
      "nonmetastatic high-grade osteosarcoma", 
      "bone tumor centers", 
      "Istituto Ortopedico Rizzoli", 
      "high-grade osteosarcoma", 
      "new active drugs", 
      "results of treatment", 
      "Rizzoli experience", 
      "amputation rate", 
      "neoadjuvant chemotherapy", 
      "resection rate", 
      "dose intensification", 
      "standard doses", 
      "grade osteosarcoma", 
      "cure rate", 
      "musculoskeletal tumors", 
      "study protocol", 
      "prechemotherapy era", 
      "rare disease", 
      "tumor center", 
      "active drug", 
      "chemotherapy", 
      "patients", 
      "osteosarcoma", 
      "extremities", 
      "biological stratification", 
      "disease", 
      "treatment", 
      "first experience", 
      "international group", 
      "prognosis", 
      "methotrexate", 
      "tumors", 
      "adriamycin", 
      "doses", 
      "cisplatin", 
      "Rizzoli", 
      "drugs", 
      "protocol", 
      "survival", 
      "rate", 
      "total", 
      "review", 
      "experience", 
      "group", 
      "aim", 
      "stratification", 
      "years", 
      "agents", 
      "center", 
      "Institute", 
      "regard", 
      "institutions", 
      "strategies", 
      "collaborative project", 
      "impact", 
      "results", 
      "era", 
      "introduction", 
      "future", 
      "different approaches", 
      "plateau", 
      "approach", 
      "intensification", 
      "project"
    ], 
    "name": "The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future", 
    "pagination": "275-287", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009972078"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4419-0284-9_14"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20213396"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4419-0284-9_14", 
      "https://app.dimensions.ai/details/publication/pub.1009972078"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:17", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_46.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4419-0284-9_14"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'


 

This table displays all metadata directly associated to this object as RDF triples.

200 TRIPLES      22 PREDICATES      99 URIs      92 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4419-0284-9_14 schema:about N45788e299b004dd695120fa272f67355
2 N713afcf7b5b141b1ae24add3038d63a4
3 Nad6aa64bc8714a3fad8525705b4f47f8
4 Nb7b71c51ee8645b7b0c8cad438a8f756
5 Nc3380c4149a848b7905d2c5fbdf7380b
6 Nd385eebdd9eb4fbeb99810f22e7276c9
7 anzsrc-for:11
8 anzsrc-for:1112
9 schema:author N5b938b8fdf654c84830eab40c7f90ad8
10 schema:datePublished 2009-08-12
11 schema:datePublishedReg 2009-08-12
12 schema:description The Bone Tumor Center of the “Istituto Ortopedico Rizzoli” was established in 1955 with the aim of studying and treating the musculoskeletal tumors. Between 1959 and 2006, 1245 patients with high grade nonmetastatic osteosarcoma of the extremity were treated at our Institute. Most of them were enrolled in study protocols.In the “prechemotherapy era”, the cure rate was 11%, with an amputation rate of 90%. Our first experience with adjuvant chemotherapy was in 1972. A total of 223 patients received adjuvant chemotherapy, with a disease-free survival (DFS) ranging from 45% to 53%, according to the chemotherapy protocol used. With the introduction of neoadjuvant chemotherapy, the resection rate increased and reached 94%, when high dose fosfamide was added to standard doses of methotrexate, cisplatin, and adriamycin.In the last few years, the results of treatment of nonmetastatic osteosarcoma of the extremity have reached a plateau (64% five-year DFS), and strategies of dose intensification are not able to improve the prognosis. Not only new active drugs, but also different approaches to the disease, are needed.In this regard, we are now investigating tumor microenvironment-targeted agents and chemotherapy protocols based on prospective biological stratification of patients.Collaborative projects with international groups and institutions are crucial for this rare disease.
13 schema:editor Nbd9674603af045778e3f4eaaf388b27b
14 schema:genre chapter
15 schema:isAccessibleForFree false
16 schema:isPartOf N999ea45f2f6b4701a935458e72d84efc
17 schema:keywords Institute
18 Istituto Ortopedico Rizzoli
19 Rizzoli
20 Rizzoli experience
21 active drug
22 adjuvant chemotherapy
23 adriamycin
24 agents
25 aim
26 amputation rate
27 approach
28 biological stratification
29 bone tumor centers
30 center
31 chemotherapy
32 chemotherapy protocols
33 cisplatin
34 collaborative project
35 cure rate
36 different approaches
37 disease
38 disease-free survival
39 dose intensification
40 doses
41 drugs
42 era
43 experience
44 extremities
45 first experience
46 future
47 grade osteosarcoma
48 group
49 high-grade osteosarcoma
50 impact
51 institutions
52 intensification
53 international group
54 introduction
55 methotrexate
56 musculoskeletal tumors
57 neoadjuvant chemotherapy
58 new active drugs
59 nonmetastatic high-grade osteosarcoma
60 nonmetastatic osteosarcoma
61 osteosarcoma
62 patients
63 plateau
64 prechemotherapy era
65 prognosis
66 project
67 protocol
68 rare disease
69 rate
70 regard
71 resection rate
72 results
73 results of treatment
74 review
75 standard doses
76 strategies
77 stratification
78 study protocol
79 survival
80 total
81 treatment
82 tumor center
83 tumors
84 years
85 schema:name The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future
86 schema:pagination 275-287
87 schema:productId N3cbfa2c4b6064ac69b0ac2807a47ee29
88 N97c87ea737be43a394d310023739488b
89 Ne5dcfbfe03e6499a945b9c1e006eec59
90 schema:publisher N3dbee5e57d0d46e6931f2a7db3bbf14a
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009972078
92 https://doi.org/10.1007/978-1-4419-0284-9_14
93 schema:sdDatePublished 2022-09-02T16:17
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N79d876533dda4590b51db7ef1206b982
96 schema:url https://doi.org/10.1007/978-1-4419-0284-9_14
97 sgo:license sg:explorer/license/
98 sgo:sdDataset chapters
99 rdf:type schema:Chapter
100 N02a99e7abaaa4301adeac2ded63180fc schema:familyName Franco
101 schema:givenName Bertoni
102 rdf:type schema:Person
103 N0cef3263ee1845cc93992bd20c7ca72f rdf:first sg:person.01210215667.35
104 rdf:rest N6a7faab43cd943819503430041ce8654
105 N278f254f245a47018c4d6a7c8c8a5a63 rdf:first sg:person.0753274552.44
106 rdf:rest Nf2a37b29e6034166baa14e237dad2977
107 N3aa5dc2c902c40bbbe6e874694931309 schema:familyName Bielack
108 schema:givenName Stefan
109 rdf:type schema:Person
110 N3cbfa2c4b6064ac69b0ac2807a47ee29 schema:name doi
111 schema:value 10.1007/978-1-4419-0284-9_14
112 rdf:type schema:PropertyValue
113 N3dbee5e57d0d46e6931f2a7db3bbf14a schema:name Springer Nature
114 rdf:type schema:Organisation
115 N45788e299b004dd695120fa272f67355 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Bone Neoplasms
117 rdf:type schema:DefinedTerm
118 N5b938b8fdf654c84830eab40c7f90ad8 rdf:first sg:person.013005321532.44
119 rdf:rest N0cef3263ee1845cc93992bd20c7ca72f
120 N648989960503466ebeaa26b444138eab rdf:first N3aa5dc2c902c40bbbe6e874694931309
121 rdf:rest rdf:nil
122 N6a7faab43cd943819503430041ce8654 rdf:first sg:person.01324444267.96
123 rdf:rest Nf2ace451c0e54fcebc0dfa01f9761752
124 N713afcf7b5b141b1ae24add3038d63a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 N79d876533dda4590b51db7ef1206b982 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 N97c87ea737be43a394d310023739488b schema:name pubmed_id
130 schema:value 20213396
131 rdf:type schema:PropertyValue
132 N999ea45f2f6b4701a935458e72d84efc schema:isbn 978-1-4419-0283-2
133 978-1-4419-0284-9
134 schema:name Pediatric and Adolescent Osteosarcoma
135 rdf:type schema:Book
136 Nad6aa64bc8714a3fad8525705b4f47f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Prognosis
138 rdf:type schema:DefinedTerm
139 Nb7b71c51ee8645b7b0c8cad438a8f756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Combined Modality Therapy
141 rdf:type schema:DefinedTerm
142 Nbd9674603af045778e3f4eaaf388b27b rdf:first Ndf5322363ef4453cbdeec33c43f37224
143 rdf:rest Nff6cd0f28fa14f1784d930702268873b
144 Nc3380c4149a848b7905d2c5fbdf7380b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Extremities
146 rdf:type schema:DefinedTerm
147 Nd24c7edbd4ca4d3da6297a185568e393 schema:familyName Bruland
148 schema:givenName Oyvind S.
149 rdf:type schema:Person
150 Nd385eebdd9eb4fbeb99810f22e7276c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Osteosarcoma
152 rdf:type schema:DefinedTerm
153 Ndf5322363ef4453cbdeec33c43f37224 schema:familyName Jaffe
154 schema:givenName Norman
155 rdf:type schema:Person
156 Ne5dcfbfe03e6499a945b9c1e006eec59 schema:name dimensions_id
157 schema:value pub.1009972078
158 rdf:type schema:PropertyValue
159 Nf2a37b29e6034166baa14e237dad2977 rdf:first sg:person.01275050611.54
160 rdf:rest rdf:nil
161 Nf2ace451c0e54fcebc0dfa01f9761752 rdf:first sg:person.01062073475.32
162 rdf:rest Nf2edf33686894213aa52d221cdb31cd2
163 Nf2edf33686894213aa52d221cdb31cd2 rdf:first N02a99e7abaaa4301adeac2ded63180fc
164 rdf:rest N278f254f245a47018c4d6a7c8c8a5a63
165 Nff6cd0f28fa14f1784d930702268873b rdf:first Nd24c7edbd4ca4d3da6297a185568e393
166 rdf:rest N648989960503466ebeaa26b444138eab
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
171 schema:name Oncology and Carcinogenesis
172 rdf:type schema:DefinedTerm
173 sg:person.01062073475.32 schema:familyName Mercuri
174 schema:givenName Mario
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062073475.32
176 rdf:type schema:Person
177 sg:person.01210215667.35 schema:familyName Palmerini
178 schema:givenName Emanuela
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
180 rdf:type schema:Person
181 sg:person.01275050611.54 schema:familyName Bacci
182 schema:givenName Gaetano
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275050611.54
184 rdf:type schema:Person
185 sg:person.013005321532.44 schema:affiliation grid-institutes:grid.419038.7
186 schema:familyName Ferrari
187 schema:givenName Stefano
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44
189 rdf:type schema:Person
190 sg:person.01324444267.96 schema:familyName Staals
191 schema:givenName Eric L.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324444267.96
193 rdf:type schema:Person
194 sg:person.0753274552.44 schema:familyName Picci
195 schema:givenName Piero
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44
197 rdf:type schema:Person
198 grid-institutes:grid.419038.7 schema:alternateName Sezione di Chemioterapia, dei Tumori dell’ Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
199 schema:name Sezione di Chemioterapia, dei Tumori dell’ Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
200 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...